The serum S100B level as a biomarker of enteroglial activation in patients with ulcerative colitis

International Journal of Inflammation

Volumn 2014, Issue , 2014, Pages

  Celikbilek, Asuman ^a   Celikbilek, Mehmet ^a   Sabah, Seda ^a   Tank, Nermin ^a   Borekci, Elif ^a   Dogan, Serkan ^b   Akin, Yavuz ^b   Baldane, Suleyman ^b   Deniz, Kemal ^b   Yilmaz, Neziha ^a   Ozbakir, Omer ^b   Yucesoy, Mehmet ^b  

^a BOZOK UNIVERSITY   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENTERIC GLIAL CELL; FEMALE; GLIA CELL; HUMAN; MALE; MODIFIED TRUELOVE WITTS SEVERITY INDEX; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; SCORING SYSTEM; ULCERATIVE COLITIS;

EID: 84899529839     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2014/986525     Document Type: Article

References (35)

1. Cirillo C., Sarnelli G., Esposito G., Grosso M., Petruzzelli R., Izzo P., Calì G., D'Armiento F. P., Rocco A., Nardone G., Iuvone T., Steardo L., Cuomo R., Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterology and Motility 2009 21 11, article e112 1209 2-s2.0-70349666893 10.1111/j.1365-2982.2009.01346.x
2. Rühl A., Nasser Y., Sharkey K. A., Enteric glia. Neurogastroenterology and Motility 2004 16 1 44 49 2-s2.0-2342623945 10.1111/j.1743-3150.2004.00474.x
3. Bush T. G., Savidge T. C., Freeman T. C., Cox H. J., Campbell E. A., Mucke L., Johnson M. H., Sofroniew M. V., Fulminant jejuno-ileitis following ablation of enteric gila in adult transgenic mice. Cell 1998 93 2 189 201 2-s2.0-0032540266 10.1016/S0092-8674(00)81571-8
4. Turco F., Sarnelli G., Cirillo C., Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut 2013 63 1 105 115
5. Cirillo C., Sarnelli G., Turco F., Mango A., Grosso M., Aprea G., Masone S., Cuomo R., Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production. Neurogastroenterology and Motility 2011 23 9 e372 e382 2-s2.0-80051702041 10.1111/j.1365-2982.2011.01748.x
6. Kubes P., McCafferty D. M., Nitric oxide and intestinal inflammation. The American Journal of Medicine 2000 109 2 150 158 2-s2.0-0034253943 10.1016/S0002-9343(00)00480-0
7. Cornet A., Savidge T. C., Cabarrocas J., Deng W.-L., Colombel J.-F., Lassmann H., Desreumaux P., Liblau R. S., Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proceedings of the National Academy of Sciences of the United States of America 2001 98 23 13306 13311 2-s2.0-0035818564 10.1073/pnas.231474098
8. Geboes K., Collins S., Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterology and Motility 1998 10 3 189 202 2-s2.0-0031832878 10.1046/j.1365-2982.1998.00102.x
9. Cabarrocas J., Savidge T. C., Liblau R. S., Role of enteric glial cells in inflammatory bowel disease. Glia 2003 41 1 81 93 2-s2.0-0037254899 10.1002/glia.10169
10. Esposito G., Cirillo C., Sarnelli G., De Filippis D., D'Armiento F. P., Rocco A., Nardone G., Petruzzelli R., Grosso M., Izzo P., Iuvone T., Cuomo R., Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 2007 133 3 918 925 2-s2.0-34548473057 10.1053/j.gastro.2007.06.009
11. Vos P. E., Jacobs B., Andriessen T. M. J. C., Lamers K. J. B., Borm G. F., Beems T., Edwards M., Rosmalen C. F., Vissers J. L. M., GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 2010 75 20 1786 1793 2-s2.0-78650013269 10.1212/WNL.0b013e3181fd62d2
12. Herrmann M., Vos P., Wunderlich M. T., de Bruijn C. H. M. M., Lamers K. J. B., Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000 31 11 2670 2677 2-s2.0-0033766279
13. Stange E. F., Travis S. P. L., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., Feakins R., Fléjou J. F., Herfarth H., Hommes D. W., Kupcinskas L., Lakatos P. L., Mantzaris G. J., Schreiber S., Villanacci V., Warren B. F., European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis 2008 2 1 1 23 2-s2.0-38749106156 10.1016/j.crohns.2007.11.001
14. Lichtiger S., Present D. H., Kornbluth A., Gelernt I., Bauer J., Galler G., Michelassi F., Hanauer S., Cyclosporine in severe ulcerative colitis refractory to steroid therapy. The New England Journal of Medicine 1994 330 26 1841 1845 2-s2.0-0028292007 10.1056/NEJM199406303302601
15. D'Haens G., Sandborn W. J., Feagan B. G., Geboes K., Hanauer S. B., Irvine E. J., Lémann M., Marteau P., Rutgeerts P., Schölmerich J., Sutherland L. R., A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007 132 2 763 786 2-s2.0-33847179443 10.1053/j.gastro.2006.12. 038
16. Singleton J. R., Smith A. G., Bromberg M. B., Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001 24 8 1448 1453 2-s2.0-0035433201
17. Rühl A., Glial cells in the gut. Neurogastroenterology and Motility 2005 17 6 777 790 2-s2.0-23244443343 10.1111/j.1365-2982.2005.00687.x
18. Cirillo C., Sarnelli G., Esposito G., Turco F., Steardo L., Cuomo R., S100B protein in the gut: the evidence for enteroglialsustained intestinal inflammation. World Journal of Gastroenterology 2011 17 10 1261 1266 2-s2.0-79955933905 10.3748/wjg.v17.i10.1261
19. Eng L. F., Ghirnikar R. S., Lee Y. L., Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochemical Research 2000 25 9-10 1439 1451 2-s2.0-0034305621
20. Von Boyen G. B. T., Steinkamp M., Reinshagen M., Schäfer K.-H., Adler G., Kirsch J., Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 2004 53 2 222 228 2-s2.0-1642451919 10.1136/gut.2003.012625
21. Anderson R. E., Hansson L. O., Nilsson O., Liska J., Settergren G., Vaage J., Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Annals of Thoracic Surgery 2001 71 5 1512 1517 2-s2.0-0034999195 10.1016/S0003-4975(01)02399-2
22. Michetti F., Corvino V., Geloso M. C., Lattanzi W., Bernardini C., Serpero L., Gazzolo D., The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. Journal of Neurochemistry 2012 120 5 644 659 2-s2.0-84857194696 10.1111/j.1471-4159.2011.07612.x
23. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I., S100B's double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta 2009 1793 6 1008 1022 2-s2.0-67349129131 10.1016/j.bbamcr.2008.11.009
24. Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. III, Araoz C., Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1989 86 19 7611 7615 2-s2.0-0001360461
25. Leach S. T., Yang Z., Messina I., Song C., Geczy C. L., Cunningham A. M., Day A. S., Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007 42 11 1321 1331 2-s2.0-35148869758 10.1080/00365520701416709
26. Donato R., RAGE: a single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Current Molecular Medicine 2007 7 8 711 724 2-s2.0-38349138516 10.2174/156652407783220688
27. Koh S. X., Lee J. K., S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Medicine 2014 44 3 369 385
28. Bartosik-Psujek H., Psujek M., Jaworski J., Stelmasiak Z., Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurologica Scandinavica 2011 123 4 252 256 2-s2.0-79952074594 10.1111/j.1600-0404.2010.01393.x
29. Nandi J., Saud B., Zinkievich J. M., Palma D. T., Levine R. A., 5-Aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats. Digestive Diseases and Sciences 2008 53 1 123 132 2-s2.0-37249087204 10.1007/s10620-007-9832-2
30. Gajalakshmi P., Priya M. K., Pradeep T., Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium. Toxicology and Applied Pharmacology 2013 269 2 121 131
31. Steiner J., Schiltz K., Walter M., Wunderlich M. T., Keilhoff G., Brisch R., Bielau H., Bernstein H.-G., Bogerts B., Schroeter M. L., Westphal S., S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology 2010 35 2 321 324 2-s2.0-73949142356 10.1016/j.psyneuen.2009.07.012
32. Gross S., van der Heide J. J. H., van Son W. J., Gans R. O. B., Foell D., Navis G., Bakker S. J. L., Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Medical Science Monitor 2010 16 7 318 324 2-s2.0-77954772700
33. O'Connell K., Thakore J., Dev K. K., Levels of S100B are raised in female patients with schizophrenia. BMC Psychiatry 2013 13, article 146
34. Pham N., Fazio V., Cucullo L., Teng Q., Biberthaler P., Bazarian J. J., Janigro D., Extracranial sources of S100B do not affect serum levels. PLoS ONE 2010 5 9 2-s2.0-77958607368 10.1371/journal.pone.0012691 e12691
35. Ehrlich S., Salbach-Andrae H., Weiss D., Burghardt R., Goldhahn K., Craciun E. M., Franke L., Uebelhack R., Klapp B. F., Lehmkuhl U., S100B in underweight and weight-recovered patients with anorexia nervosa. Psychoneuroendocrinology 2008 33 6 782 788 2-s2.0-46249119651 10.1016/j.psyneuen.2008.03.004